北京大学学报(医学版) ›› 2022, Vol. 54 ›› Issue (4): 592-594. doi: 10.19723/j.issn.1671-167X.2022.04.002

• 专家笔谈 • 上一篇    下一篇

上尿路尿路上皮癌的淋巴清扫

张崔建*(),何志嵩,周利群   

  • 收稿日期:2022-04-07 出版日期:2022-08-18 发布日期:2022-08-11
  • 通讯作者: 张崔建 E-mail:surgeon_zhang@126.com

崔建 张*(),志嵩 何,利群 周   

  • Received:2022-04-07 Online:2022-08-18 Published:2022-08-11
  • Contact: 崔建 张 E-mail:surgeon_zhang@126.com

RICH HTML

  

关键词: 上尿路尿路上皮癌, 淋巴结清扫, 预后, 泌尿系肿瘤

中图分类号: 

  • R737.1
1 Roupret M , Babjuk M , Burger M , et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update[J]. Eur Urol, 2021, 79 (1): 62- 79.
doi: 10.1016/j.eururo.2020.05.042
2 Siegel RL , Miller KD , Fuchs HE , et al. Cancer Statistics, 2021[J]. CA Cancer J Clin, 2021, 71 (1): 7- 33.
doi: 10.3322/caac.21654
3 Nortier JL , Martinez MCM , Schmeiser HH , et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)[J]. New Engl J Med, 2000, 342 (23): 1686- 1692.
doi: 10.1056/NEJM200006083422301
4 Huang PC , Huang CY , Huang SW , et al. High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan[J]. Int J Urol, 2006, 13 (7): 864- 869.
doi: 10.1111/j.1442-2042.2006.01429.x
5 Karl A , Carroll PR , Gschwend JE , et al. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer[J]. Eur Urol, 2009, 55 (4): 826- 835.
doi: 10.1016/j.eururo.2009.01.004
6 Mason RJ , Kassouf W , Bell DG , et al. The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: The Canadian experience[J]. Urology, 2012, 79 (4): 840- 845.
doi: 10.1016/j.urology.2011.11.058
7 Roscigno M , Brausi M , Heidenreich A , et al. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer[J]. Eur Urol, 2011, 60 (4): 776- 783.
doi: 10.1016/j.eururo.2011.07.009
8 Dorfman RE , Alpern MB , Gross BH , et al. Upper abdominal lymph nodes: criteria for normal size determined with CT[J]. Radiology, 1991, 180 (2): 319- 322.
doi: 10.1148/radiology.180.2.2068292
9 Voskuilen CS , Schweitzer D , Jensen JB , et al. Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography with computed tomography for lymph node staging in patients with upper tract urothelial carcinoma[J]. Eur Urol Oncol, 2020, 3 (1): 73- 79.
doi: 10.1016/j.euo.2019.09.004
10 Kondo T , Nakazawa H , Ito F , et al. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract[J]. Urology, 2007, 69 (2): 265- 269.
doi: 10.1016/j.urology.2006.10.014
11 Kondo T , Tanabe K . Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract[J]. Int J Urol, 2012, 19 (8): 710- 721.
doi: 10.1111/j.1442-2042.2012.03009.x
12 Matin SF , Sfakianos JP , Espiritu PN , et al. Patterns of lymphatic metastases in upper tract urothelial carcinoma and proposed dissection templates[J]. J Urol, 2015, 194 (6): 1567- 1574.
doi: 10.1016/j.juro.2015.06.077
13 Roscigno M , Cozzarini C , Bertini R , et al. Prognostic value of lymph node dissection in patients with muscleinvasive transitional cell carcinoma of the upper urinary tract[J]. Eur Urol, 2008, 53 (4): 794- 802.
doi: 10.1016/j.eururo.2008.01.008
14 Secin FP , Koppie TM , Salamanca JI , et al. Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer[J]. Int J Urol, 2007, 14 (1): 26- 32.
doi: 10.1111/j.1442-2042.2006.01664.x
15 Gschwend JE , Heck MM , Lehmann J , et al. Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: Survival results from a prospective, randomized trial[J]. Eur Urol, 2019, 75 (4): 604- 611.
doi: 10.1016/j.eururo.2018.09.047
16 Ouzzane A , Colin P , Ghoneim TP , et al. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy[J]. World J Urol, 2013, 31 (1): 189- 197.
doi: 10.1007/s00345-012-0983-1
17 Burger M , Shariat SF , Fritsche HM , et al. No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: A retrospective international, multi-institutional study[J]. World J Urol, 2011, 29 (4): 465- 472.
doi: 10.1007/s00345-011-0705-0
18 Roscigno M , Shariat SF , Margulis V , et al. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy[J]. J Urol, 2009, 181 (6): 2482- 2489.
doi: 10.1016/j.juro.2009.02.021
19 Lughezzani G , Jeldres C , Isbarn H , et al. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma[J]. Urology, 2010, 75 (1): 118- 124.
doi: 10.1016/j.urology.2009.07.1296
20 Roscigno M , Shariat SF , Freschi M , et al. Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer[J]. Urology, 2009, 74 (5): 1070- 1074.
doi: 10.1016/j.urology.2009.04.084
21 Brausi MA , Gavioli M , De Luca G , et al. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: Impact on survival[J]. Eur Urol, 2007, 52 (5): 1414- 1418.
doi: 10.1016/j.eururo.2007.04.070
22 Kondo T , Hara I , Takagi T , et al. Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: A prospective study[J]. Int J Urol, 2014, 21 (5): 453- 459.
doi: 10.1111/iju.12338
23 Cho KS , Choi HM , Koo K , et al. Clinical significance of lymph node dissection in patients with muscle-invasive upper urinary tract transitional cell carcinoma treated with nephroureterectomy[J]. J Korean Med Sci, 2009, 24 (4): 674- 678.
doi: 10.3346/jkms.2009.24.4.674
24 Miyake H , Hara I , Gohji K , et al. The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract[J]. Br J Urol, 1998, 82 (4): 494- 498.
doi: 10.1046/j.1464-410X.1998.00800.x
25 Kondo T , Nakazawa H , Ito F , et al. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract[J]. J Urol, 2007, 178 (4 Pt 1): 1212- 1217.
26 Rao SR , Correa JJ , Sexton WJ , et al. Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma[J]. BJU Int, 2012, 110 (11 pt B): E475- E480.
27 Abe T , Takada N , Matsumoto R , et al. Outcome of regional lymphadenectomy in accordance with primary tumor location on laparoscopic nephroureterectomy for urothelial carcinoma of the upper urinary tract: A prospective study[J]. J Endourol, 2015, 29 (3): 304- 309.
doi: 10.1089/end.2014.0369
[1] 欧俊永,倪坤明,马潞林,王国良,颜野,杨斌,李庚午,宋昊东,陆敏,叶剑飞,张树栋. 肌层浸润性膀胱癌合并中高危前列腺癌患者的预后因素[J]. 北京大学学报(医学版), 2024, 56(4): 582-588.
[2] 刘帅,刘磊,刘茁,张帆,马潞林,田晓军,侯小飞,王国良,赵磊,张树栋. 伴静脉癌栓的肾上腺皮质癌的临床治疗及预后[J]. 北京大学学报(医学版), 2024, 56(4): 624-630.
[3] 虞乐,邓绍晖,张帆,颜野,叶剑飞,张树栋. 具有低度恶性潜能的多房囊性肾肿瘤的临床病理特征及预后[J]. 北京大学学报(医学版), 2024, 56(4): 661-666.
[4] 周泽臻,邓绍晖,颜野,张帆,郝一昌,葛力源,张洪宪,王国良,张树栋. 非转移性T3a肾细胞癌患者3年肿瘤特异性生存期预测[J]. 北京大学学报(医学版), 2024, 56(4): 673-679.
[5] 方杨毅,李强,黄志高,陆敏,洪锴,张树栋. 睾丸鞘膜高分化乳头状间皮肿瘤1例[J]. 北京大学学报(医学版), 2024, 56(4): 741-744.
[6] 曾媛媛,谢云,陈道南,王瑞兰. 脓毒症患者发生正常甲状腺性病态综合征的相关因素[J]. 北京大学学报(医学版), 2024, 56(3): 526-532.
[7] 彭圣嘉,祁雨,孙丽杰,李丹,王新宇,韩江莉,陈宝霞,张媛. 传入压力反射衰竭合并低钠血症1例[J]. 北京大学学报(医学版), 2024, 56(2): 357-361.
[8] 苏俊琪,王晓颖,孙志强. 舌鳞状细胞癌根治性切除术后患者预后预测列线图的构建与验证[J]. 北京大学学报(医学版), 2024, 56(1): 120-130.
[9] 李建斌,吕梦娜,池强,彭一琳,刘鹏程,吴锐. 干燥综合征患者发生重症新型冠状病毒肺炎的早期预测[J]. 北京大学学报(医学版), 2023, 55(6): 1007-1012.
[10] 刘欢锐,彭祥,李森林,苟欣. 基于HER-2相关基因构建风险模型用于膀胱癌生存预后评估[J]. 北京大学学报(医学版), 2023, 55(5): 793-801.
[11] 薛子璇,唐世英,邱敏,刘承,田晓军,陆敏,董靖晗,马潞林,张树栋. 青年肾肿瘤伴瘤栓的临床病理特征及预后分析[J]. 北京大学学报(医学版), 2023, 55(5): 802-811.
[12] 刘慧丽,吕彦函,王晓晓,李民. 老年患者腹腔镜泌尿系肿瘤根治术后慢性疼痛的影响因素[J]. 北京大学学报(医学版), 2023, 55(5): 851-856.
[13] 卢汉,张建运,杨榕,徐乐,李庆祥,郭玉兴,郭传瑸. 下颌牙龈鳞状细胞癌患者预后的影响因素[J]. 北京大学学报(医学版), 2023, 55(4): 702-707.
[14] 时云飞,王豪杰,刘卫平,米岚,龙孟平,刘雁飞,赖玉梅,周立新,刁新婷,李向红. 血管免疫母细胞性T细胞淋巴瘤临床与分子病理学特征分析[J]. 北京大学学报(医学版), 2023, 55(3): 521-529.
[15] 朱晓娟,张虹,张爽,李东,李鑫,徐玲,李挺. 人表皮生长因子受体2低表达乳腺癌的临床病理学特征及预后[J]. 北京大学学报(医学版), 2023, 55(2): 243-253.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!